ArticleVirus genes2026
Epidemiological trends of HCV subtypes in China.
Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
While China has made notable progress toward the World Health Organization's goal of hepatitis elimination, substantial challenges continue to persist. In recent years, the prevalence of hepatitis C virus (HCV) in China has remained high. Understanding the distribution and trends of HCV genotypes is crucial for effective disease management. This study systematically analyzes the distribution and changes in various HCV subtypes across China, utilizing data from 29,874 cases identified through high-quality detection methods in 123 articles published between 1994 and 2024. Our findings indicate that the five most prevalent HCV subtypes are 1b, 3b, 6a, 2a, and 3a. The 1b subtype is primarily found in Guangdong (26.71%), Heilongjiang (25.16%), Yunnan (8.42%), Guizhou (6.85%) and Hubei (5.52%). The 2a subtype is concentrated in Heilongjiang (55.85%), Guangdong (8.35%) and Yunnan (6.7%), while subtypes 3b, 3a, and 6a are more common in southern provinces such as Yunnan, Guizhou, and Guangdong. Importantly, the distribution of subtypes in Southern and Southwestern China differs significantly from other areas, with genotypes 3 and 6 comprising over 50% of cases. This study highlights the need for ongoing surveillance and targeted strategies in HCV management to adapt to the evolving landscape of viral genotypes in China.
Indexed as
Identifiers
42533205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.